Nov 2018;25(11):1275-1285
There was no significant differences between the effects of the daily oral maintenance dosages of 2 g and 6 g on heart failure (RR = 0.53, 95% CI [0.25-1.13], P = 0.10), unstable angina (RR = 0.90, 95% CI [0.51-1.58], P = 0.71), or myocardial reinfarction (RR = 0.74, 95% CI [0.30-1.80], P = 0.50)
FG supervised the project and finalized the manuscript
Appetite suppression was observed at doses 0.3 mg while significant reductions in circulating triglycerides, branched-chained amino-acids and fasting and postprandial glucagon levels were also seen, along with increasing insulin secretion
PubMed laboratory research record [PMID: 12904603] PubMed record related to this compound for laboratory literature review